Abraham Chaibi is cofounder and CEO of Sapho Bio. The San Carlos company automates qc workflows for pharmaceutical companies. Its rapid sterility method returns results in 2 days, compared with 14 for the standard USP<71> method.
He arrived at biotech through software. As cofounder and CTO of Dexterity Capital from 2017 to 2024, he led the engineering behind the firm's low-latency trading platform. Earlier, he built data systems at LiveRamp and worked on optimization problems, NFL scheduling among them, for an analytics consultancy.
Abraham holds a BSE in mechanical engineering, cum laude. He is a licensed pilot.
Cofounded a San Carlos lab automation company rebuilding independent testing workflows, starting with pharmaceutical products. Sapho Bio runs USP-validated lot release and stability studies, and its rapid sterility method returns results in 2 days compared with 14 for the standard USP<71> method. Grew the customer base to 30 enterprises and thousands of tests processed each month.
Company Description
Pharmaceutical testing lab in San Carlos, California, combining AI tooling with automated hardware.
